Controlling nerve injury repair revealed in Monash University study
Monash University scientists are one step closer to solving the riddle of how nerves can self-heal.
The scientists from the Biomedicine Discovery Institute (BDI) have found signals in the tiny transparent roundworm that control the mechanism by which severed nerves self-heal.
Moreover, they have demonstrated how to control this process genetically, raising hopes for treating nerve injuries in humans in the future.
Nervous system injuries, such as those to the spinal cord, can cause lifelong disabilities because our bodies are unable to fully repair themselves.
Led by Monash BDI’s Dr Brent Neumann, and in collaboration with researchers from the Queensland Brain Institute at The University of Queensland, the discovery builds on the team’s landmark 2015 findings, in which the scientists discovered ‘axonal fusion’, a highly efficient yet simple repair process.
Axonal fusion, observed in several nematode worm species, allows severed nerve cells (neurons) to form a bridge across their damaged section.
The latest research, published today in the journal Proceedings of the National Academy of Sciences (PNAS), established that axonal fusion restores full function to damaged nerves.
The scientists used a laser beam to sever a single neuron in the one-millimetre long C. elegans, a transparent nematode, and observed how it regenerated, finding that the function associated with this neuron was restored within 48 hours.
The two ends of the nerve were able to recognise each other and reconnect due to specific ‘save-me’ signals displayed on the surface of the damaged nerve.
The researchers demonstrated that a level of 'save-me' signals was essential for the process to occur and that it was possible to manipulate this genetically.
“Basically the ‘save-me’ signal is really controlling whether you can regrow nerves through this fully functional method of regeneration. It’s critical for the process,” said Dr Neumann, who heads the Nervous System Development and Repair laboratory at BDI.
“The nematode worm is ideal for research into nerve injury repair because it has a very simple nervous system and because the biological mechanisms involved are ‘conserved’ and similar to those in humans,” Dr Neumann said.
“The big advantage for us in using the nematode worm for this study is that we can look at individual nerves and see how they respond, and see in very precise detail what’s actually happening at that individual neuron level, which is much more difficult, if not impossible in other more complex systems,” he said.
“Humans have billions of neurons, whereas these worms have only 302.”
First author, Ms Zehra Abay said, “Genetically we can boost the capacity of the neurons to actively mediate a response after injury, and if we do that we can get better rates of this axonal-fusion process.”
Associate Professor Massimo Hilliard, Principal Research Fellow at the Queensland Brain Institute, said the discovery adds another important step towards finding new ways to treat nerve injuries.
“Demonstrating that axonal fusion provides functional recovery of the severed nerve is essential for this type of repair to eventually be exploited for nerve repair in humans,” Associate Professor Hilliard said.
“By understanding precisely how this repair process occurs, we can modulate it more effectively and hopefully apply it to mammalian systems.”
This research was supported by the National Health and Medical Research Council.
Read the full paper titled Phosphatidylserine ‘save-me’ signals drive functional recovery of severed axons in Caenorhabditis eleganspublished today in Proceedings of the National Academy of Sciences (PNAS)
About the Monash Biomedicine Discovery Institute
Committed to making the discoveries that will relieve the future burden of disease, the newly established Monash Biomedicine Discovery Institute at Monash University brings together more than 120 internationally-renowned research teams. Our researchers are supported by world-class technology and infrastructure, and partner with industry, clinicians and researchers internationally to enhance lives through discovery.